We are live on ! Find out more
PTLA

Portola Pharmaceuticals, Inc.
PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

62 hedge funds and large institutions have $485M invested in Portola Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+62
Holders Change %
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
62
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
BJ
51
BlackRock Japan
Japan
$150K +$121K +6,103 New
BA
52
BlackRock Advisors
Delaware
$114K +$92.1K +4,636 New
SO
53
STRS Ohio
Ohio
$111K +$89.4K +4,500 New
Citigroup
54
Citigroup
New York
$111K +$89.7K +4,512 New
NFA
55
Nationwide Fund Advisors
Ohio
$76K +$61.6K +3,099 New
TRCT
56
Tower Research Capital (TRC)
New York
$58K +$46.8K +2,357 New
Ameriprise
57
Ameriprise
Minnesota
$15K +$12K +604 New
SSG
58
Summit Securities Group
New York
$12K +$9.94K +500 New
Barclays
59
Barclays
United Kingdom
$12K +$10.1K +508 New
BlackRock
60
BlackRock
New York
$6K +$5.11K +257 New
PTC
61
Private Trust Company
Ohio
$2K +$1.83K +92 New
PG
62
PEAK6 Group
Illinois
$491 +$398K +20,000 New

PTLA Hedge Fund Activity: Q2 2013 in Review

62 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q2 2013, worth a combined $485M.

Buyers outnumbered sellers: 62 funds opened new PTLA positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.

  • 62 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $485M of Portola Pharmaceuticals, Inc. stock for Q2 2013.
  • 62 funds opened new Portola Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +62 holders.

Based on aggregated 13F filings for Q2 2013.